Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
3,211,934
-
Shares change
-
-1,229,419
-
Total reported value, excl. options
-
$8,401,029
-
Value change
-
-$3,165,078
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$2.59
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2018
29 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2018.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,211,934 shares
of 107,573,681 outstanding shares and own 2.99% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (1,814,152 shares), Knoll Capital Management, LP (321,413 shares), Vanguard Group Inc (297,752 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (224,400 shares), GEODE CAPITAL MANAGEMENT, LLC (100,890 shares), MORGAN STANLEY (83,700 shares), Leisure Capital Management (72,479 shares), CREDIT SUISSE AG/ (65,000 shares), NORTHERN TRUST CORP (38,032 shares), and OPPENHEIMER & CO INC (36,966 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.